Abstract:Abstract Abstract 3093 Poster Board III-30 The side population (SP) phenotype, defined as the verapamil-blockable ability to efflux the nucleic acid dye Hoechst 33342, has been used to enrich for stem cells in several human normal tissues, cancers, and multiple cell lines including blood cells, and thus may be useful for the identification and isolation of cancer stem cells, which has emerged as a new therapeutic target for cancer treatment. However, the molecular mechanism(s) operating in SP cells remain unclear. Previous studies show that the stem cell factor, SALL4 plays a central role in the self-renewal of embryonic and leukemic stem cells. In this study, we determined the role of SALL4 in side population (SP). Using FACS sorting, we found the presence of SP fractions in four leukemic cell lines: HL-60, NB-4, RPMI8226 and KG1a. SALL4 expression was more abundant in SP cells compared with non-SP cells by 2- 4 fold in these leukemic cell lines. Knockdown of SALL4 in purified SP cells resulted in a reduction of SP population, indicating that SALL4 is required for the self-renewal of SP cells in this culture system. Since the side population phenotype is known to be mediated by the ATP-binding cassette proteins, we further investigated whether SALL4 could regulate the ATP transporters in SP cells. Chromatin immunoprecipitation (ChIP), luciferase assays and real-time PCR analysis demonstrated that SALL4 could bind to the promoter region of ABCA3, one of the ABC transporters, and activated its expression. In addition, while overexpression of SALL4 led to drug resistance in cell lines, SALL4-knockdown cells displayed more sensitive to drug treatments than the control cells. Further more, SALL4 expression was associated with primary AML treatment status (N= 64 cases), with higher SALL4 mRNA expression seen in drug resistance and partial remission patients than that from complete remission cases. Taken together, our results suggest that SALL4 plays an important in the sensitivity to drug treatment, at least in part, through the maintenance of SP cells, and is responsible for drug-resistance in leukemia. Disclosures No relevant conflicts of interest to declare.

Structural Insights into AT-rich DNA Recognition by SALL Family Proteins

Structural Studies of SALL Family Protein Zinc Finger Cluster Domains in Complex with DNA Reveal Preferential Binding to an AATA Tetranucleotide Motif

Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression

Leukemic Survival Factor Sall4 Contributes to Defective Dna Damage Repair

SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and inducesAML in transgenic mice

A SALL4/MLL/HOXA9 Pathway in Murine and Human Myeloid Leukemogenesis.

Cooperative Action between SALL4A and TET Proteins in Stepwise Oxidation of 5-Methylcytosine.

Sall4 guides p53-mediated enhancer interference upon DNA damage in mouse embryonic stem cells

SALL4: an emerging cancer biomarker and target.

Structural Basis for Recognition of AT-rich DNA by Unrelated Xenogeneic Silencing Proteins.

The new advance of SALL4 in cancer: Function, regulation, and implication

Sall4, a Stem Cell Factor, Promotes Chemoresistance by Regulates the Side Population Cell Phenotype.

SALL4, a Novel Oncogene Induces Myelodysplastic Syndrome and Acute Myeloid Leukemia Via Wnt/β-Catenin Pathway.

Histone Lysine-Specific Demethylase 1 (LSD1) Protein is Involved in Sal-like Protein 4 (Sall4)-Mediated Transcriptional Repression in Hematopoietic Stem Cells.

Crystal Structure of the Ubiquitin-like Domain-CUT Repeat-like Tandem of Special AT-rich Sequence Binding Protein 1 (SATB1) Reveals a Coordinating DNA-binding Mechanism

The Structural Basis for the Oligomerization of the N-terminal Domain of SATB1

Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6

Structural and biochemical characterization of the ALX4 dimer reveals novel insights into how disease alleles impact ALX4 function

Sall4 regulates posterior trunk mesoderm development by promoting mesodermal gene expression and chromatin accessibility that promotes WNT signaling and represses neural genes within the mesoderm

Constitutive Expression of SALL4B in Mice Confers Properties of Leukemic Stem Cells to Committed Hematopoietic Progenitors.

Diversification and conservation of DNA binding specificities of SPL family of transcription factors